Mackenzie Financial’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.2M | Sell |
44,162
-1,577
| -3% | -$885K | 0.02% | 410 |
|
|
2026
Q1 | $25.7M | Sell |
45,739
-450
| -1% | -$289K | 0.03% | 360 |
|
|
2025
Q4 | $31.5M | Sell |
46,189
-57,545
| -55% | -$39.2M | 0.04% | 320 |
|
|
2025
Q3 | $66.3M | Sell |
103,734
-45,788
| -31% | -$27.8M | 0.08% | 211 |
|
|
2025
Q2 | $80.2M | Buy |
149,522
+1,199
| +0.8% | +$573K | 0.1% | 177 |
|
|
2025
Q1 | $62.3M | Sell |
148,323
-8,197
| -5% | -$3.56M | 0.09% | 190 |
|
|
2024
Q4 | $64.7M | Buy |
156,520
+110,000
| +236% | +$48.2M | 0.09% | 186 |
|
|
2024
Q3 | $23.5M | Sell |
46,520
-2,747
| -6% | -$1.33M | 0.03% | 319 |
|
|
2024
Q2 | $24M | Buy |
49,267
+5,863
| +14% | +$2.94M | 0.04% | 301 |
|
|
2024
Q1 | $23.4M | Sell |
43,404
-148
| -0.3% | -$80.9K | 0.03% | 316 |
|
|
2023
Q4 | $24.2M | Sell |
43,552
-126
| -0.3% | -$59.2K | 0.04% | 309 |
|
|
2023
Q3 | $18.6M | Buy |
43,678
+326
| +0.8% | +$163K | 0.03% | 332 |
|
|
2023
Q2 | $21.3M | Buy |
43,352
+30,621
| +241% | +$14.7M | 0.03% | 317 |
|
|
2023
Q1 | $6.37M | Sell |
12,731
-714
| -5% | -$342K | 0.01% | 506 |
|
|
2022
Q4 | $5.49M | Buy |
13,445
+1,172
| +10% | +$455K | 0.01% | 506 |
|
|
2022
Q3 | $4M | Buy |
12,273
+61
| +0.5% | +$22.4K | 0.01% | 564 |
|
|
2022
Q2 | $4.28M | Sell |
12,212
-957
| -7% | -$390K | 0.01% | 562 |
|
|
2022
Q1 | $7.2M | Sell |
13,169
-667
| -5% | -$351K | 0.01% | 516 |
|
|
2021
Q4 | $9.11M | Sell |
13,836
-4,726
| -25% | -$2.97M | 0.01% | 495 |
|
|
2021
Q3 | $11.5M | Buy |
18,562
+2,038
| +12% | +$1.37M | 0.02% | 438 |
|
|
2021
Q2 | $10.4M | Buy |
16,524
+5,847
| +55% | +$3.23M | 0.01% | 445 |
|
|
2021
Q1 | $5.22M | Buy |
10,677
+4,791
| +81% | +$2.4M | 0.01% | 529 |
|
|
2020
Q4 | $2.94M | Sell |
5,886
-1,718
| -23% | -$769K | 0.01% | 532 |
|
|
2020
Q3 | $2.99M | Sell |
7,604
-695
| -8% | -$257K | 0.01% | 485 |
|
|
2020
Q2 | $2.74M | Buy |
8,299
+3,467
| +72% | +$1M | 0.01% | 491 |
|
|
2020
Q1 | $1.17M | Buy |
4,832
+3,453
| +250% | +$901K | ﹤0.01% | 609 |
|
|
2019
Q4 | $360K | Buy |
+1,379
| New | +$363K | ﹤0.01% | 923 |
|
|
2019
Q2 | – | Sell |
-26,310
| Closed | -$5.88M | – | 1171 |
|
|
2019
Q1 | $5.88M | Sell |
26,310
-14,397
| -35% | -$2.97M | 0.01% | 484 |
|
|
2018
Q4 | $7.57M | Buy |
+40,707
| New | +$8.35M | 0.02% | 423 |
|
|
2017
Q1 | – | Sell |
-11,942
| Closed | -$1.4M | – | 670 |
|
|
2016
Q4 | $1.4M | Sell |
11,942
-114,231
| -91% | -$13M | 0.01% | 414 |
|
|
2016
Q3 | $14.2M | Sell |
126,173
-45,700
| -27% | -$4.82M | 0.09% | 188 |
|
|
2016
Q2 | $16M | Sell |
171,873
-28,362
| -14% | -$2.44M | 0.09% | 207 |
|
|
2016
Q1 | $15.7M | Sell |
200,235
-35,100
| -15% | -$2.53M | 0.14% | 162 |
|
|
2015
Q4 | $17.2M | Buy |
+235,335
| New | +$16.8M | 0.11% | 185 |
|
Other funds holding IDXX
Mackenzie Financial's IDXX Position: Q2 2026 in Review
Mackenzie Financial reduced its Idexx Laboratories (IDXX) stake by 3.4% in Q2 2026, selling an estimated $885K and leaving 44,162 shares worth $23.2M. The position accounts for 0.02% of the portfolio, ranked #410.
Mackenzie Financial first reported a position in IDXX in Q4 2015 and has held it in 34 quarters since. The position peaked at $80.2M in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Mackenzie Financial held 44,162 shares of Idexx Laboratories worth $23.2M as of Q2 2026.
- Mackenzie Financial sold 1,577 Idexx Laboratories shares in Q2 2026, an estimated $885K.
- Idexx Laboratories made up 0.02% of Mackenzie Financial's portfolio in Q2 2026, its #410 holding.
- Mackenzie Financial first reported a position in Idexx Laboratories in Q4 2015 and has held it in 34 quarters since.
- Mackenzie Financial's Idexx Laboratories position peaked at $80.2M in Q2 2025.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.